“Drugs That Flopped”
Drug companies withhold unfavorable data (negative studies) on profitable drugs and fail to file timely reports on safety and effectiveness, sometimes for years. Avandia, Celebrex, Zyprexia and Vioxx come to mind. They hire “investigators” and consultants to produce questionable favorable studies and have them published in journals to legitimize their exalted and mellifluous claims. About 350 people die daily from drug reactions or 128,000 per year. There appears to be an epidemic of harmful allowable FDA approved drugs, which have scarce benefits to any patients. Massive lobbying programs and political contributions perpetuate the corruption and abuse of patients. Pharmaceutical companies continuously emphasize how deeply society depends on their development of innovative products to improve health. But in fact, these companies are mostly developing drugs that are mostly little better than existing products but have the potential to cause widespread adverse reactions even when appropriately prescribed. Drug companies pour hundreds of millions and even billions of dollars into pharmaceutical development, hoping that one will bring in the big bucks and make the whole process worthwhile. Pharmaceutical companies pour fortunes into drug development but sometimes their products are still colossal failures. There are plenty of drugs that fail to live up to their initial promise.